Page last updated: 2024-08-25

oxazolidin-2-one and Soft Tissue Infections

oxazolidin-2-one has been researched along with Soft Tissue Infections in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	38 (50.00)	29.6817
2010's	31 (40.79)	24.3611
2020's	7 (9.21)	2.80

Authors

Authors	Studies
Huang, H; Yuan, H; Yuan, Z; Zhang, Y; Zhao, X	2
Cao, G; Chen, Y; Guo, B; Huang, H; Li, Y; Wu, H; Wu, J; Wu, X; Yang, W; Yu, J; Yuan, H; Yuan, Z; Zhang, J; Zhang, Y	1
Rodgers, MP; Wertheim, HFL	1
Chopra, S; Dasgupta, A; Kaul, G	1
Abreu, MA; Carvalho, R; Couto de Carvalho, A; Reis, E; Santos, T	1
Antadze, T; Bradley, JS; Broyde, N; Butterton, JR; Chou, MZ; De Anda, CS; Kim, JY; Ninov, B; Sears, PS; Tayob, MS	1
Bouza, E; Burillo, A; Muñoz, P	1
ALeryan, M; Delpech, P; Gemmell, C; Jones, B; Lang, S	1
Hall, RG; Pass, SE; Putnam, WC; Smith, WJ	1
Ariza, B; Cortés, JA; De la Rosa, ZR; Gualtero, S; Leal, AL; Montañes, AM; Ovalle, MV; Rodríguez, JY; Sussman, O; Torres, MDP	1
Bassetti, M; Carnelutti, A; Righi, E	1
Bensaci, M; Corey, R; De Anda, C; Goering, R; Moran, G; Prokocimer, P; Sandison, T	1
Chen, X; Dong, BR; Liu, GJ; Wu, T; Yang, M; Yue, J	1
Chambers, RB; Deminski, MC; Haider, S; Louder, AM; Pasquale, MK	1
Dumitrescu, O; Lina, G	1
Baguneid, M; Bassetti, M; Bouza, E; Dryden, M; Nathwani, D; Wilcox, M	1
Bassetti, M; Cadeo, B; Cojutti, PG; Pea, F; Pecori, D	1
Burian, A; Eslam, RB; Frenzel, D; Hammer, A; Kloft, C; Matzneller, P; Minichmayr, IK; Oesterreicher, Z; Sauermann, R; Vila, G; Zeitlinger, M	1
Chambers, R; Charbonneau, C; Eckmann, C; Haider, S; Hajek, P; Lawson, W; Li, JZ; Macahilig, C; Nathwani, D; Simoneau, D; Solem, CT; Stephens, JM	1
Fan, W; Kongnakorn, T; LaPensee, KT; Pelligra, CG; Revankar, N; Ward, AJ	1
Steiner, M	1
Cardona, AF; Wilson, SE	1
Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F	1
Esposito, S; Leone, S; Noviello, S	1
Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X	1
Drewelow, B; Haase, G; Klammt, S; Majcher-Peszynska, J; Mundkowski, R; Pietsch, A; Sass, M; Schareck, W	1
Ariza, J; Cabellos, C; Cabo, J; Domenech, A; Euba, G; Gudiol, F; Murillo, O; Tubau, F; Verdaguer, R	1
Bounthavong, M; Hsu, DI; Okamoto, MP	1
Besnier, JM; De Cock, E; Dupon, M; Duttagupta, S; Guery, B; Levrat, F; Sorensen, S	1
Dodds, TJ; Hawke, CI	1
Beibei, L; Mengli, C; Nan, B; Rui, W; Xuhong, Y; Yun, C	1
Chambers, HF; Deshpande, LM; Diep, BA; Jones, RN; Mendes, RE; Sader, HS	1
Bounthavong, M; Hsu, DI	2
Stein, GE; Wells, EM	1
Baruch, AM; Bhattacharyya, H; Dryden, MS; Itani, KM; Kunkel, MJ; Weigelt, JA	1
Concia, E	1
Joukhadar, C; Mauric, O; Popovic, M; Scharnagl, E; Schintler, MV; Spendel, S; Traunmüller, F	1
Bien, P; Bulitta, JB; Corey, GR; DeAnda, C; Mehra, P; Prokocimer, P; Surber, J	1
Dryden, M; Eckmann, C	1
Gould, FK	1
Almenoff, J; Andrae, D; Covington, P; Davenport, JM; Liverman, L; McIntyre, G; O'Riordan, W	1
Baruch, AM; Bhattacharyya, H; Biswas, P; Itani, KM; Reisman, A	1
Cheung, AL; Cho, JS; Donegan, NP; Guo, Y; Miller, LS; Ramos, RI	1
Hau, T	1
Wilson, SE	1
Blatun, LA	1
Arya, SC	1
Bruss, JB; Cammarata, SK; Le, V; Solomkin, JS; Wilson, SE	1
Gauzit, R	1
Cepeda, JA; Cooper, B; Hails, J; Hayman, S; Jones, K; Kibbler, C; Kwaku, F; Shaw, S; Shulman, R; Singer, M; Taylor, L; Whitehouse, T; Wilson, AP	1
Bodmann, KF	1
Schweiger, ES; Weinberg, JM	1
Broder, KW; Forrest, A; Moise, PA; Schentag, JJ; Schultz, RO	1
LaRosa, SP; Tomecki, KJ	1
Chen, YS; Kim, WJ; Lee, SC	1
Citron, DM; Goldstein, EJ; Havlichek, DH; Kak, V; Peloquin, CA; Schooley, SL; Stein, GE; Tyrrell, KL	1
Polk, HC; Sharpe, JN; Shively, EH	1
Dryden, M; Itani, K; Knirsch, C; Lau, W; Stevens, D; Weigelt, J	1
Wilcox, MH	1
Charles, PG; Grayson, ML; Howden, BP; Johnson, PD; Ward, PB	1
Duttagupta, S; Itani, KM; Li, JZ; Weigelt, J	1
Kalil, AC; Puumala, S; Stoner, J	1
Peppard, WJ; Weigelt, JA	1
Bush, LM; de Almeida, KN	1
Buonuomini, AR; Fontana, C; Leonardi, L; Leonardis, F; Natoli, S; Testore, GP	1
Grau, S; Marin-Casino, M; Mateu-de Antonio, J	1
Chiodo, F; Manfredi, R; Nanetti, A; Sabbatani, S	1
Liu, LZ; McCollum, M; Sorensen, SV	1
De Cock, E; Duttagupta, S; Resch, A; Schürmann, D; Sorensen, SV	1
Bruss, JB; Duvall, SE; Hafkin, B; McConnell-Martin, MA; Smith, LG; Stevens, DL; Todd, WM	1
Fung, HB; Kirschenbaum, HL; Ojofeitimi, BO	1
Wilson, P	1
Hedström, SA	1

Reviews

28 review(s) available for oxazolidin-2-one and Soft Tissue Infections

Article	Year
The role of tedizolid in skin and soft tissue infections. Current opinion in infectious diseases, 2018, Volume: 31, Issue:2 Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Tetrazoles; Treatment Outcome	2018
An evaluation of tedizolid for the treatment of MRSA infections. Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:13 Topics: Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Randomized Controlled Trials as Topic; Soft Tissue Infections; Staphylococcal Infections; Tetrazoles	2018
Current role of oxazolidinones and lipoglycopeptides in skin and soft tissue infections. Current opinion in infectious diseases, 2019, Volume: 32, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Humans; Lipoglycopeptides; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Teicoplanin; Tetrazoles	2019
Linezolid versus vancomycin for skin and soft tissue infections. The Cochrane database of systematic reviews, 2013, Jul-12, Issue:7 Topics: Acetamides; Adult; Anti-Bacterial Agents; Drug Eruptions; Humans; Length of Stay; Linezolid; Oxazolidinones; Pruritus; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Thrombocytopenia; Vancomycin	2013
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20 Suppl 4 Topics: Acetamides; Anti-Bacterial Agents; Europe; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Practice Guidelines as Topic; Risk Factors; Soft Tissue Infections; Staphylococcal Skin Infections	2014
Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Sep-15, Volume: 61 Suppl 2 Topics: Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Daptomycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; North America; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections	2015
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs. Internal and emergency medicine, 2016, Volume: 11, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin	2016
[Skin and soft tissue infections: current therapeutic options]. Le infezioni in medicina, 2008, Volume: 16, Issue:2 Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daptomycin; Humans; Linezolid; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Tigecycline; Time Factors; Treatment Outcome	2008
Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model. International journal of clinical practice, 2009, Volume: 63, Issue:3 Topics: Acetamides; Cost-Benefit Analysis; Decision Support Techniques; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Risk Factors; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin	2009
Linezolid versus vancomycin for MRSA skin and soft tissue infections (systematic review and meta-analysis). ANZ journal of surgery, 2009, Volume: 79, Issue:9 Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Randomized Controlled Trials as Topic; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Vancomycin	2009
Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials. International journal of antimicrobial agents, 2010, Volume: 35, Issue:1 Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin	2010
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Current medical research and opinion, 2010, Volume: 26, Issue:2 Topics: Acetamides; Aged; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin	2010
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Current medical research and opinion, 2010, Volume: 26, Issue:3 Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2010
[Therapy of SSTI and role of tigecycline]. Le infezioni in medicina, 2009, Volume: 17 Suppl 4 Topics: Acetamides; Anti-Bacterial Agents; Combined Modality Therapy; Comorbidity; Cross Infection; Daptomycin; Debridement; Drainage; Drug Therapy, Combination; Humans; Italy; Linezolid; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Sepsis; Skin Diseases, Bacterial; Soft Tissue Infections; Tigecycline; Wound Infection	2009
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin. European journal of medical research, 2010, Nov-30, Volume: 15, Issue:12 Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Microbial; Humans; Linezolid; Minocycline; Oxazolidinones; Skin Diseases; Soft Tissue Infections; Tigecycline; Vancomycin	2010
Linezolid: safety and efficacy in special populations. The Journal of antimicrobial chemotherapy, 2011, Volume: 66 Suppl 4 Topics: Acetamides; Anti-Bacterial Agents; Endocarditis, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Osteoarthritis; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; United Kingdom	2011
Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections. Expert review of pharmacoeconomics & outcomes research, 2012, Volume: 12, Issue:6 Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Cost-Benefit Analysis; Economics, Pharmaceutical; Health Care Costs; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin	2012
Efficacy and safety of linezolid in the treatment of skin and soft tissue infections. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:7 Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Humans; Linezolid; Multicenter Studies as Topic; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections	2002
Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections. Surgical infections, 2001,Spring, Volume: 2, Issue:1 Topics: Acetamides; Anti-Infective Agents; Clinical Trials as Topic; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Surgical Wound Infection	2001
[Modern potential of antimicrobial therapy in the treatment of wounded soft tissue infections and osteomyelitis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2002, Volume: 47, Issue:9 Topics: Acetamides; Anti-Infective Agents; Bacterial Infections; Humans; Linezolid; Osteomyelitis; Oxazolidinones; Soft Tissue Infections; Wound Infection	2002
[Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment]. Pharmazie in unserer Zeit, 2004, Volume: 33, Issue:1 Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Infectious; Soft Tissue Infections	2004
Novel antibacterial agents for skin and skin structure infections. Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Oxazolidinones; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Virginiamycin	2004
Antibiotics: what's new? Cutis, 2004, Volume: 73, Issue:5 Suppl Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Streptogramins	2004
Update on linezolid: the first oxazolidinone antibiotic. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:13 Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Positive Cocci; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Practice Guidelines as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Teicoplanin; Vancomycin	2005
Role of linezolid in the treatment of complicated skin and soft tissue infections. Expert review of anti-infective therapy, 2006, Volume: 4, Issue:3 Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections	2006
Linezolid: an oxazolidinone antimicrobial agent. Clinical therapeutics, 2001, Volume: 23, Issue:3 Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Drug Interactions; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Soft Tissue Infections; Vancomycin Resistance	2001
Linezolid: a new antibiotic for gram-positive infections. Hospital medicine (London, England : 1998), 2001, Volume: 62, Issue:11 Topics: Acetamides; Anti-Infective Agents; Drug Costs; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections	2001
[Linezolide--an antibiotic with new action mechanism]. Lakartidningen, 2002, Mar-14, Volume: 99, Issue:11 Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Controlled Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections	2002

Trials

16 trial(s) available for oxazolidin-2-one and Soft Tissue Infections

Article	Year
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections. The Journal of antimicrobial chemotherapy, 2022, 05-29, Volume: 77, Issue:6 Topics: Adult; Anti-Bacterial Agents; Double-Blind Method; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pyridones; Soft Tissue Infections; Treatment Outcome	2022
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections-authors' response. The Journal of antimicrobial chemotherapy, 2022, 10-28, Volume: 77, Issue:11 Topics: Adult; Anti-Bacterial Agents; Double-Blind Method; Humans; Linezolid; Oxazolidinones; Pyridones; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome	2022
Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections. The Pediatric infectious disease journal, 2021, 03-01, Volume: 40, Issue:3 Topics: Abscess; Adolescent; Anti-Bacterial Agents; Female; Global Health; Humans; Male; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Tetrazoles; Wound Infection	2021
Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection. Journal of clinical pharmacology, 2014, Volume: 54, Issue:9 Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Diabetes Mellitus, Type 2; Female; Foot Diseases; Humans; Linezolid; Male; Microdialysis; Middle Aged; Oxazolidinones; Soft Tissue Infections	2014
Linezolid for the treatment of infections caused by Gram-positive pathogens in China. International journal of antimicrobial agents, 2008, Volume: 32, Issue:3 Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin	2008
Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid. Journal of clinical microbiology, 2010, Volume: 48, Issue:2 Topics: Acetamides; Americas; Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Bacterial; Europe; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Oxazolidinones; Soft Tissue Infections; South Africa; Staphylococcal Skin Infections; Vancomycin	2010
Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. American journal of surgery, 2010, Volume: 199, Issue:6 Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chi-Square Distribution; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome; Vancomycin	2010
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organophosphates; Oxazoles; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Young Adult	2011
Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infection. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12 Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; Double-Blind Method; Female; Fluoroquinolones; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcus aureus; Treatment Outcome; United States; Young Adult	2011
Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Critical Care; Critical Illness; Cross Infection; Double-Blind Method; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Pneumonia, Bacterial; Respiratory Tract Infections; Sepsis; Soft Tissue Infections; Teicoplanin; Treatment Outcome	2004
Efficacy and tolerability of linezolid in treating severe skin and soft tissue infections caused by Gram-positive pathogens. Journal of the Formosan Medical Association = Taiwan yi zhi, 2004, Volume: 103, Issue:5 Topics: Acetamides; Cellulitis; Consumer Product Safety; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Protein Synthesis Inhibitors; Skin Diseases, Bacterial; Soft Tissue Infections	2004
Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis. The Annals of pharmacotherapy, 2005, Volume: 39, Issue:3 Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Cellulitis; Drug Resistance, Multiple, Bacterial; Female; Half-Life; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Obesity; Oxazolidinones; Serum Bactericidal Test; Skin Diseases, Bacterial; Soft Tissue Infections	2005
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. American journal of surgery, 2005, Volume: 189, Issue:4 Topics: Acetamides; Administration, Oral; Adult; Aged; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin	2005
Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:6 Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Female; Humans; Internationality; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin	2005
Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA). International journal of antimicrobial agents, 2005, Volume: 26, Issue:6 Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Americas; Anti-Bacterial Agents; Anti-Infective Agents; Asia; Europe; Female; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin; Methicillin Resistance; Middle Aged; New Zealand; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin	2005
Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:12 Topics: Acetamides; Anti-Infective Agents; Dicloxacillin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Oxacillin; Oxazolidinones; Penicillins; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome	2000

Other Studies

32 other study(ies) available for oxazolidin-2-one and Soft Tissue Infections

Article	Year
Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections. Antimicrobial agents and chemotherapy, 2022, 06-21, Volume: 66, Issue:6 Topics: Adult; Anti-Bacterial Agents; China; Humans; Oxazolidinones; Pharmacology, Clinical; Pyridones; Soft Tissue Infections; Staphylococcus aureus	2022
Comment on: A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections. The Journal of antimicrobial chemotherapy, 2022, 10-28, Volume: 77, Issue:11 Topics: Adult; Double-Blind Method; Humans; Linezolid; Oxazolidinones; Soft Tissue Infections	2022
Contezolid in complicated skin and soft tissue infection. Drugs of today (Barcelona, Spain : 1998), 2022, Volume: 58, Issue:7 Topics: Anti-Bacterial Agents; China; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pyridones; Soft Tissue Infections; United States	2022
Evidence Associated with the Use of Oxazolidinones in the Treatment of Skin and Skin Structure Infections: A Retrospective Study. Acta medica portuguesa, 2020, Feb-03, Volume: 33, Issue:2 Topics: Humans; Oxazolidinones; Retrospective Studies; Soft Tissue Infections; Vancomycin	2020
An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections. Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:1 Topics: Anti-Bacterial Agents; Biofilms; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus; Tetrazoles	2018
In vitro activity of tedizolid and other comparator drugs in methicillin-resistant Staphylococcus aureus isolates in skin and soft tissue infections in seven Colombian hospitals Biomedica : revista del Instituto Nacional de Salud, 2018, 12-01, Volume: 38, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colombia; Female; Hospitals; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Prospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Tetrazoles; Young Adult	2018
tedizolid (SIVEXTRO) in skin and soft-tissue infections. Prescrire international, 2017, Volume: 26, Issue:180* Topics: Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Tetrazoles	2017
Comparison of the microbiological efficacy of tedizolid and linezolid in acute bacterial skin and skin structure infections: pooled data from phase 3 clinical trials. Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Clinical Trials, Phase III as Topic; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections; Tetrazoles; Treatment Outcome; Young Adult	2019
Out-of-pocket costs and prescription reversals with oral linezolid. The American journal of managed care, 2013, Volume: 19, Issue:9 Topics: Acetamides; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Databases, Factual; Drug Substitution; Financing, Personal; Health Maintenance Organizations; Humans; Linear Models; Linezolid; Medicare Part D; Middle Aged; Oxazolidinones; Patient Readmission; Pneumonia, Bacterial; Retrospective Studies; Soft Tissue Infections; United States; Young Adult	2013
What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20 Suppl 4 Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Soft Tissue Infections; Staphylococcal Skin Infections	2014
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: a case report. Therapeutic drug monitoring, 2014, Volume: 36, Issue:5 Topics: Acetamides; Adult; Anti-Infective Agents; Drug Interactions; Female; Humans; Hypothyroidism; Linezolid; Oxazolidinones; Soft Tissue Infections; Thyroxine	2014
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. International journal of antimicrobial agents, 2014, Volume: 44, Issue:1 Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Drug Administration Schedule; Europe; Female; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Patient Discharge; Practice Guidelines as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin	2014
Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections. Journal of medical economics, 2014, Volume: 17, Issue:10 Topics: Acetamides; Acute Disease; Administration, Intravenous; Anti-Bacterial Agents; Daptomycin; Health Expenditures; Humans; Linezolid; Oxazolidinones; Patient Discharge; Skin Diseases, Bacterial; Soft Tissue Infections; United States; Vancomycin	2014
Cochrane in context: Linezolid versus vancomycin for skin and soft tissue infections. Evidence-based child health : a Cochrane review journal, 2014, Volume: 9, Issue:1 Topics: Acetamides; Anti-Bacterial Agents; Humans; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Vancomycin	2014
Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections. European journal of clinical pharmacology, 2008, Volume: 64, Issue:11 Topics: Acetamides; Aged; Anti-Infective Agents; Diabetic Foot; Female; Humans; Inflammation; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Permeability; Soft Tissue Infections; Staphylococcal Skin Infections	2008
Efficacy of linezolid alone and in combination with rifampin in staphylococcal experimental foreign-body infection. The Journal of infection, 2008, Volume: 57, Issue:3 Topics: Acetamides; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Therapy, Combination; Foreign Bodies; Linezolid; Male; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Rats; Rifampin; Soft Tissue Infections; Staphylococcal Infections; Treatment Outcome	2008
Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France. Medecine et maladies infectieuses, 2009, Volume: 39, Issue:5 Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Decision Trees; Drug Monitoring; France; Gram-Positive Bacterial Infections; Humans; Inpatients; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections	2009
Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacterial Infections; Bone and Bones; Diabetes Mellitus, Type 2; Diabetic Foot; Humans; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Plasma; Skin; Soft Tissue Infections	2010
Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis. Clinical therapeutics, 2012, Volume: 34, Issue:8 Topics: Acetamides; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clinical Trials, Phase IV as Topic; Female; Humans; Infusions, Intravenous; Linezolid; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Oxazolidinones; Propensity Score; Randomized Controlled Trials as Topic; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin	2012
In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Acetamides; Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacterial Load; Bridged Bicyclo Compounds, Heterocyclic; Clindamycin; Community-Acquired Infections; Daptomycin; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Doxycycline; Linezolid; Luminescent Measurements; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mupirocin; Oxazolidinones; Skin; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Wound Healing	2013
Therapeutic efficacy of linezolid in extended clinical practice. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:2 Topics: Acetamides; Anti-Infective Agents; Drug Labeling; Drug Storage; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Assessment; Sensitivity and Specificity; Skin Diseases, Bacterial; Soft Tissue Infections; Temperature	2003
A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid. American journal of surgery, 2003, Volume: 185, Issue:4 Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Cloxacillin; Female; Humans; Linezolid; Male; Middle Aged; Outcome Assessment, Health Care; Oxazolidinones; Penicillins; Prognosis; Risk; Severity of Illness Index; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Failure	2003
[Contribution of linezolid to the treatment of complicated infections of the skin and soft tissues]. Presse medicale (Paris, France : 1983), 2003, Apr-05, Volume: 32, Issue:13 Pt 2 Topics: Acetamides; Anti-Infective Agents; Controlled Clinical Trials as Topic; France; Humans; Linezolid; Oxacillin; Oxazolidinones; Penicillins; Skin Diseases, Bacterial; Soft Tissue Infections	2003
Clinical experience with linezolid in conjunction with wound coverage techniques for skin and soft-tissue infections and postoperative osteomyelitis. Annals of plastic surgery, 2004, Volume: 52, Issue:4 Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Debridement; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Osteomyelitis; Oxazolidinones; Postoperative Complications; Skin Transplantation; Soft Tissue Infections; Staphylococcus aureus; Surgical Flaps; Surgical Procedures, Operative; Treatment Outcome; Vancomycin Resistance; Wounds and Injuries	2004
Improved outcomes with linezolid for methicillin-resistant Staphylococcus aureus infections: better drug or reduced vancomycin susceptibility? Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:11 Topics: Acetamides; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2005
Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus? Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:5 Topics: Acetamides; Anti-Bacterial Agents; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin	2006
Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection. Annals of internal medicine, 2006, Aug-01, Volume: 145, Issue:3 Topics: Acetamides; Anti-Infective Agents; Community-Acquired Infections; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus	2006
Linezolid as rescue drug: a clinical case of soft tissue infection caused by a Staphylococcus aureus strain resistant in vivo to teicoplanin. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:4 Topics: Acetamides; Aged; Airway Obstruction; Anti-Infective Agents; Cellulitis; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Male; Oxazolidinones; Salvage Therapy; Soft Tissue Infections; Staphylococcal Infections; Teicoplanin	2006
Comment: impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:12 Topics: Acetamides; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2006
A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone. Le infezioni in medicina, 2006, Volume: 14, Issue:3 Topics: Acetamides; Acute Disease; Anti-Infective Agents; Glycopeptides; Humans; Joint Diseases; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Severity of Illness Index; Soft Tissue Infections; Staphylococcal Infections	2006
A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in Clinical therapeutics, 2007, Volume: 29, Issue:3 Topics: Acetamides; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Health Care Costs; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; United States; Vancomycin	2007
Cost-effectiveness of linezolid versus vancomycin for hospitalised patients with complicated skin and soft-tissue infections in Germany. The European journal of health economics : HEPAC : health economics in prevention and care, 2009, Volume: 10, Issue:1 Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Decision Support Techniques; Delphi Technique; Germany; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin	2009